Merck & Co Inc (MRK)

MRK (NYSE:Drugs)
$58.15
pos +0.00
+0.00%
Today's Range: 57.92 - 58.36 | MRK Avg Daily Volume: 9,028,800
Last Update: 07/25/14 - 4:03 PM EDT
Volume: 0
YTD Performance: 16.18%
Open: $0.00
Previous Close: $58.21
52 Week Range: $44.62 - $59.84
Oustanding Shares: 2,922,376,244
Market Cap: 170,111,521,163
6-Month Chart
TheStreet Ratings Grade for MRK
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 6 6 6 6
Moderate Buy 0 0 0 1
Hold 6 8 8 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 2.00 2.14 2.14 1.96
Latest Dividend: 0.44
Latest Dividend Yield: 3.02%
Dividend Ex-Date: 09/11/14
Price Earnings Ratio: 38.30
Price Earnings Comparisons:
MRK Sector Avg. S&P 500
38.30 38.30 28.93
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.59% 20.72% 62.02%
GROWTH 12 Mo 3 Yr CAGR
Revenue -6.80 -0.04 -0.01
Net Income -28.30 3.60 0.65
EPS -26.70 4.32 0.74
Earnings for MRK:
EBITDA 14.65B
Revenue 44.03B
Average Earnings Estimates
Qtr (06/14) Qtr (09/14) FY (12/14) FY (12/15)
Average Estimate $0.82 $0.89 $3.49 $3.67
Number of Analysts 7 6 11 10
High Estimate $0.84 $0.93 $3.54 $3.79
Low Estimate $0.80 $0.86 $3.43 $3.40
Prior Year $0.84 $0.92 $3.49 $3.49
Growth Rate (Year over Year) -2.89% -3.80% 0.05% 5.10%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
By

Jim Cramer

 | Jul 17, 2014 | 7:10 AM EDT

If you're worried about these moves, it's time to cash out.

By

Jim Cramer

 | Jul 15, 2014 | 2:15 PM EDT

If you don't like speculation, just hike the margin requirement.

By

John Reese

 | Jul 11, 2014 | 10:00 AM EDT

Cisco, Merck and Intel earn approval from two rigorous stock-picking strategies.

By

Jim Cramer

 | Jul 9, 2014 | 6:44 AM EDT

Here are several themes that are still working -- and now you can get in at a bargain.

By

Jim Cramer

 | Jul 7, 2014 | 11:18 AM EDT

A wave of M&A in the health sector makes sense.

By

Jim Cramer

 | Jul 7, 2014 | 9:12 AM EDT

Standing still is no longer an option.

By

Jim Cramer

 | Jul 2, 2014 | 5:46 AM EDT

Shares of the top Dow performers since 16,000 still reflect leaner times.

By

Jim Cramer

 | Jun 16, 2014 | 3:38 PM EDT

It helps to understand how the market digests different fears.

bullishMerck target raised at BofA/Merrill

Jun 12, 2014 | 7:37 AM EDT

Shares of MRK now seen reaching $65, according to Bank of America/Merrill Lynch. Expect higher Hepatitis C sales and the Indentix purchase should add to earnings. Buy rating.  

updateGoldman Healthcare Conf.

Jun 12, 2014 | 7:12 AM EDT

Goldman Sachs Healthcare Conference (Day 3 of 3) - 06/10/14 - 06/12/14 Los Angeles, CA

REAL MONEY PRO'S BEST IDEAS

Columnist Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.